MedPath

Diode Laser and SRP in Chronic Periodontitis

Not Applicable
Completed
Conditions
Periodontitis
Interventions
Procedure: Sham-laser +SRP
Procedure: PAPD+SRP
Registration Number
NCT02407379
Lead Sponsor
Odontostomatologic Laser Therapy Center, Florence, Italy
Brief Summary

The purpose of this study is to compare the efficacy of photoablative and photodynamic diode laser in adjunct to scaling-root planing (PAPD+SRP) and SRP alone for the treatment of periodontitis.

Detailed Description

The present study is a randomized, blinded, controlled clinical trial, which used a split-mouth design. All patients were informed individually about the nature of the proposed treatment, and informed consent forms were signed. Twenty-four patients were studied. Maxillary left or right quadrants were randomly assigned to PAPD laser treatment or sham-treatment and SRP. PAPD consisted of: i) photoablative gingival epithelium with diode laser (λ 810 nm, 1 W); ii) photodynamic treatments (4-10 weekly) with diode laser (λ 635 nm, 100 mW) and 0.3% methylene blue as photoactive antiseptic, performed after SRP. Sham-treatment was similar but with switched off laser.

Efficacy evaluations, including probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP) was performed at baseline ,1year, and year 3 using a conventional manual periodontal probe. Polymorphonuclear leukocytes (PMN), erythrocytes (RBC), damaged epithelial cells (DEC) and bacteria were assayed by cytofluorescence on gingival exfoliative samples at baseline, 6 month and 1, 3, 5 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  1. Periodontitis:Presence of at least two teeth with at least one site with pocket probing depth (PD) ranging from 4 to 10 mm in each upper maxillary quadrant and with bleeding on probing (BOP)
  2. A minimum of five natural teeth in each studied quadrant.
Exclusion Criteria
  1. History of systemic diseases (diabetes mellitus, cancer, HIV, metabolic and endocrine diseases)
  2. Pregnancy or lactation
  3. Chronic high-dose steroid use
  4. Previous or current radiation or immunosuppressive therapies
  5. Ongoing orthodontic treatments
  6. Extensive carious lesions
  7. Recurrent antibiotic medications during the 6 months preceding the study
  8. Class III tooth mobility
  9. Heavy contamination by spirochetes and fungal pathogens on tongue and oral mucosa

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Sham-laser + SRPSham-laser +SRPThis quadrant, randomly selected in each patients, undergoes treatment with sham-laser + SRP
PAPD+SRP QuadrantPAPD+SRPThis quadrant, randomly selected in each patients, undergoes treatment with PAPD+ SRP
Primary Outcome Measures
NameTimeMethod
PDbaseline, 1 year

Change in probing pocket depth

Secondary Outcome Measures
NameTimeMethod
CALbaseline, 1 year

Change in mean attachment level

BoPbaseline, 1 year

Change in mean bleeding on probing

PMN, DEC, bacteriabaseline, 1 year

Change in mean additional disease markers, namely polymorphonuclear leukocytes (PMN), erythrocytes (RBC), damaged epithelial cells (DEC) and bacteria were assayed by cytofluorescence on gingival exfoliative samples.

Patient-reported outcomesbaseline, 1 year

Individual evaluation of pain/discomfort assessed by a visual analogue score interview

Trial Locations

Locations (1)

Odontostomatologic laser therapy center

🇮🇹

Florence, Italy

© Copyright 2025. All Rights Reserved by MedPath